[Effect of fibrinolysis on possible thrombocytic disorders].
D000614:Aminocaproates / Q000627:therapeutic use; D007611:Aprotinin / Q000627:therapeutic use; D001791:Blood Platelet Disorders / Q000150:complications*; D001792:Blood Platelets / Q000502:physiology; D005342:Fibrinolysis; D006470:Hemorrhage / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D011183:Postoperative Complications / Q000188:drug therapy / Q000209:etiology*; D011468:Prostatectomy; D011470:Prostatic Hyperplasia / Q000601:surgery; D011471:Prostatic Neoplasms / Q000601:surgery; D011517:Prothrombin Time; D013925:Thromboplastin
D000614:Aminocaproates; D013925:Thromboplastin; D007611:Aprotinin
Einfluss der Fibrinolyse auf mögliche thrombocytäre Funktionsstörungen.